Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Inc. buy Leerink Partnrs

Start price
€30.60
16.08.23 / 50%
Target price
-
16.08.24
Performance (%)
66.67%
End price
€51.00
17.08.24
Summary
This prediction ended on 17.08.24 with a price of €51.00. With a performance of 66.67% the BUY prediction by Leerink_Partnrs was a big success. Leerink_Partnrs has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. 0.980% 0.980% 55.120%
iShares Core DAX® 1.056% 1.056% 18.108%
iShares Nasdaq 100 -1.886% -0.160% 26.970%
iShares Nikkei 225® 2.553% 4.359% 17.676%
iShares S&P 500 -0.434% 0.224% 24.986%

Comments by Leerink_Partnrs for this prediction

In the thread Discuss Cytokinetics Inc.

Cytokinetics, Incorporated (NASDAQ: CYTK) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.
Ratings data for CYTK provided by MarketBeat

In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) 66.67%
Target price
Change
Ends at 16.08.24

Die von Leerink_Partnrs gewählte maximale Laufzeit wurde überschritten